UK Medical Marijuana Provider Releaf Partners With Glass Pharms To Secure Medical—Grade Cannabis

One of the UK’s fastest-growing medical marijuana providers, Releaf, confirmed Tuesday it has partnered with domestic producer of medical cannabis, Glass Pharms. Under the partnership, Glass Pharms will provide Releaf with 145kg (320 pounds) of high-quality medical-grade cannabis.

“This partnership with Glass Pharms marks a significant milestone not just for Releaf but for the entire UK medical cannabis industry,” stated Tim Kirby, managing director of Releaf. “It’s the largest deal in UK history and underlines the growing recognition of medical cannabis as a legitimate healthcare solution. By securing a high-quality domestic supply of this medication, we’re not just meeting demand-we’re setting a new standard for reliability and patient care in this sector.”

Releaf expects for its patient base to exceed the current size of the entire UK sector (around 45,000 patients) in the next 12 months. The company …

Full story available on Benzinga.com